Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,781 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $574.58 | 6 | $0 (2024) |
| ABBVIE INC. | $481.72 | 10 | $0 (2024) |
| GENZYME CORPORATION | $357.44 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $207.17 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $199.17 | 2 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $191.89 | 6 | $0 (2024) |
| Abbott Laboratories | $174.75 | 2 | $0 (2024) |
| Kyowa Kirin, Inc. | $168.82 | 2 | $0 (2024) |
| Eisai Inc. | $159.78 | 3 | $0 (2024) |
| Genentech USA, Inc. | $125.04 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,599 | 50 | SK Life Science, Inc. ($574.58) |
| 2023 | $986.40 | 10 | GENZYME CORPORATION ($279.56) |
| 2022 | $882.78 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($117.83) |
| 2021 | $313.34 | 3 | Genentech USA, Inc. ($125.04) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $67.88 | General |
| Category: Men's Health | ||||||
| 12/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Neuromodulation | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $153.43 | General |
| Category: Diabetes Care | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $118.92 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $116.94 | General |
| 10/31/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Neurology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $119.62 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: PAIN | ||||||
| 10/24/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.40 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Neurology | ||||||
| 10/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Neurology | ||||||
| 09/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.10 | General |
| Category: Neurology | ||||||
| 08/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Neurology | ||||||
| 08/13/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Food and Beverage | In-kind items and services | $77.88 | General |
| Category: Genetic Disease | ||||||
| 07/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: PAIN | ||||||
| 07/24/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $141.70 | General |
| 07/24/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $46.27 | General |
| 07/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/13/2024 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 35 | 35 | $1,641 | $1,608 |
| 2021 | 8 | 256 | 265 | $22,688 | $10,207 |
| 2020 | 5 | 103 | 105 | $7,291 | $3,290 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $1,173 | $1,150 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $468.00 | $458.64 | 98.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 87 | 91 | $10,920 | $4,116 | 37.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 66 | 68 | $2,652 | $1,280 | 48.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $2,780 | $1,272 | 45.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 21 | 21 | $1,004 | $1,004 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 20 | $2,500 | $988.53 | 39.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $1,089 | $651.24 | 59.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,197 | $549.29 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 21 | 21 | $546.00 | $345.62 | 63.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 18 | $2,502 | $966.40 | 38.6% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 46 | 46 | $1,794 | $878.60 | 49.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $2,085 | $706.36 | 33.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 13 | 13 | $572.00 | $528.00 | 92.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 13 | $338.00 | $210.86 | 62.4% |
About Akram Mirdamadiha
Akram Mirdamadiha is a Family healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1992135909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Akram Mirdamadiha has received a total of $4,781 in payments from pharmaceutical and medical device companies, with $2,599 received in 2024. These payments were reported across 73 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,781).
As a Medicare-enrolled provider, Mirdamadiha has provided services to 394 Medicare beneficiaries, totaling 405 services with total Medicare billing of $15,106. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Primary Care
- Location Plano, TX
- Active Since 11/13/2013
- Last Updated 10/15/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992135909
Products in Payments
- XCOPRI (Drug) $373.49
- UBRELVY (Drug) $286.72
- NURTEC ODT (Drug) $215.04
- XIFAXAN (Drug) $207.17
- Leqembi (Drug) $159.78
- FREESTYLE LIBRE 3 (Device) $153.43
- Xofluza (Drug) $125.04
- VALTOCO (Drug) $125.00
- Inpefa (Drug) $121.81
- FARXIGA (Drug) $120.16
- ZEPOSIA (Drug) $119.62
- Kerendia (Drug) $117.83
- KRYSTEXXA (Biological) $117.29
- AUSTEDO (Drug) $110.94
- Crysvita (Drug) $106.58
- GEMTESA (Drug) $104.69
- VRAYLAR (Drug) $104.07
- SUNOSI (Drug) $100.04
- Seglentis (Drug) $94.69
- Austedo XR (Drug) $88.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Plano
Kori Nelson, Fnp-C, FNP-C
Family — Payments: $107,146
Abiola Amure, Fnp-C, FNP-C
Family — Payments: $14,511
Vicki Redpath
Family — Payments: $10,534
Katelynn Mann, Msn, Fnp, MSN, FNP
Family — Payments: $10,231
Blen Daniel, Fnp, FNP
Family — Payments: $9,096
Ronnie Terry, Aprn, Rnfa, APRN, RNFA
Family — Payments: $8,895